Clinical Trials Browser

Phase 1/2 × Urinary Bladder Neoplasms × Lenalidomide × Clear all

NCT01342172 2019-04-23

Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma

Phase 1/2 Terminated

9 enrolled 9 charts

Urinary Bladder Neoplasms, Neoplasm Metastasis